Moffitt Cancer Center has conducted the first prospective study to investigate genomic biomarkers associated with aggressive disease in African American men with prostate cancer. The study results were published in the Journal of the National Cancer Institute.
To highlight the importance of lifesaving cancer research, National Cancer Research Month, led by the American Association for Cancer Research (AACR), is recognized during May. Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, has curated a selection of ongoing research focusing on cancer disparities which features members from the Cancer Health Equity Center of Excellence.
Compared with all other racial and ethnic groups in the United States, Black people are disproportionally more affected by lung cancer. Sharon R. Pine, PhD, a resident member of Rutgers Cancer Institute of New Jersey, associate professor of Pharmacology and Medicine at Rutgers Robert Wood Johnson Medical School and member of the Cancer Health Equity Center of Excellence e, discusses the barriers that Black people face, the research being done on racial health disparities and how action can be taken now.
In a new article published in Clinical Cancer Research, Moffitt Cancer Center researchers describes the immune-oncologic differences in prostate cancer tumors of African American men and how those variations may be exploited to develop more personalized treatment approaches for this population.